A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2])

Am J Cardiol. 2002 Feb 1;89(3):326-30. doi: 10.1016/s0002-9149(01)02235-4.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary
  • Coronary Angiography
  • Coronary Thrombosis / drug therapy*
  • Coronary Thrombosis / mortality
  • Coronary Thrombosis / surgery*
  • Disease-Free Survival
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Graft Occlusion, Vascular / drug therapy
  • Graft Occlusion, Vascular / mortality
  • Graft Occlusion, Vascular / surgery
  • Hemorheology
  • Humans
  • Infusions, Intra-Arterial
  • Male
  • Middle Aged
  • Thrombectomy* / instrumentation
  • Thrombectomy* / methods
  • Treatment Outcome
  • United States
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Urokinase-Type Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Urokinase-Type Plasminogen Activator